We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
(+27%)
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
15.66%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.23% |
| 2 | Technology | 20.39% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 8.95% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Labcorp
LH
$25B
| $39.8M | 0.2% |
246,041
-421,209
| -63% | -$66.8M |
|
127
Viatris
VTRS
$20.4B
| $39.6M | 0.2% |
2,672,364
+2,052,792
| +331% | +$32.8M |
|
128
Thermo Fisher Scientific
TMO
$213B
| $39.6M | 0.2% |
89,625
+75,689
| +543% | +$31.3M |
|
129
Omnicom Group
OMC
$21.6B
| $39.4M | 0.2% |
+796,546
| New | +$42.6M |
|
|
XEC
130
DELISTED
CIMAREX ENERGY CO
XEC
| $39.4M | 0.2% |
1,618,195
+368,911
| +30% | +$9.71M |
|
|
FBC
131
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $39.1M | 0.2% |
1,320,627
+606,718
| +85% | +$18.3M |
|
132
CALL
Alibaba
BABA
$293B
| $38.8M | 0.2% |
132,000
+37,000
| +39% | +$9.75M |
|
133
United Parks & Resorts
PRKS
$2.1B
| $38.6M | 0.2% |
+1,958,089
| New | +$35.8M |
|
134
Acadia Healthcare
ACHC
$2.76B
| $38.4M | 0.2% |
1,302,924
+896,015
| +220% | +$26M |
|
|
VNET
135
VNET Group
VNET
$2.04B
| $38.2M | 0.2% |
+1,648,638
| New | +$38.4M |
|
136
Avery Dennison
AVY
$13B
| $38.1M | 0.19% |
297,759
+200,839
| +207% | +$23.7M |
|
|
VG
137
DELISTED
Vonage Holdings Corporation
VG
| $37.8M | 0.19% |
3,697,940
+986,486
| +36% | +$10.9M |
|
138
Hershey
HSY
$35.2B
| $37.6M | 0.19% |
262,336
+210,072
| +402% | +$29.8M |
|
139
Aon
AON
$76.5B
| $37.5M | 0.19% |
181,702
-4,514
| -2% | -$901K |
|
|
PPD
140
DELISTED
PPD, Inc. Common Stock
PPD
| $37.4M | 0.19% |
+1,011,470
| New | +$32M |
|
|
CCXI
141
DELISTED
ChemoCentryx, Inc.
CCXI
| $37.2M | 0.19% |
679,281
+555,696
| +450% | +$29.9M |
|
|
PRSP
142
DELISTED
Perspecta Inc. Common Stock
PRSP
| $37.2M | 0.19% |
1,913,865
+654,433
| +52% | +$13.8M |
|
143
TJX Companies
TJX
$174B
| $37.1M | 0.19% |
+666,238
| New | +$35.9M |
|
144
Duke Energy
DUK
$97.8B
| $36.7M | 0.19% |
414,654
-529,835
| -56% | -$43.7M |
|
145
Sanofi
SNY
$103B
| $36.6M | 0.19% |
728,824
-113,936
| -14% | -$5.87M |
|
|
SGI
146
Somnigroup International
SGI
$13.7B
| $36.4M | 0.19% |
1,632,272
+202,112
| +14% | +$4.18M |
|
147
Amphenol
APH
$198B
| $35.9M | 0.18% |
1,327,724
+25,008
| +2% | +$659K |
|
148
Texas Roadhouse
TXRH
$13.5B
| $35.8M | 0.18% |
588,340
+58,491
| +11% | +$3.42M |
|
149
Vertex Pharmaceuticals
VRTX
$121B
| $35.4M | 0.18% |
+130,200
| New | +$35.9M |
|
150
CALL
iShares China Large-Cap ETF
FXI
$4.35B
| $34.9M | 0.18% |
+830,000
| New | +$35.7M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
- Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.